Preparation of dextran glassy particles through freezing-induced phase separation

International Journal of Pharmaceutics

Volumn 339, Issue 1-2, 2007, Pages 76-83

  Yuan, Weien ^a   Wu, Fei ^a   Geng, Yan ^a   Xu, Songlin ^a   Jin, Tuo ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Dextran glassy particles; PEG; Phase separation; Uniform solution

Indexed keywords

ACETONITRILE; CARBON TETRACHLORIDE; DEXTRAN; DICHLOROMETHANE; MACROGOL; POLYSACCHARIDE; REAGENT; WATER;

AIR; ARTICLE; BIOTECHNOLOGY; CONCENTRATION (PARAMETERS); CROSS LINKING; DENSITY; DISSOLUTION; FREEZE DRYING; FREEZING; MOLECULAR WEIGHT; PARTICLE SIZE; PHASE SEPARATION; PRIORITY JOURNAL; TEMPERATURE; THERMOGRAPHY;

DEXTRANS; DRUG CARRIERS; FREEZING; PARTICLE SIZE; POLYETHYLENE GLYCOLS; X-RAY DIFFRACTION;

EID: 34250874458     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2007.02.018     Document Type: Article

References (32)

1. Al-Ruqaie I.M., Kasapis S., and Abeysekera R. Structural properties of pectin-gelatin gels. Part II: effect of sucrose/glucose syrup. Carbohydr. Polym. 34 (1997) 309-321
2. Andya J.D., Maa Y.F., Costantino H.R., Nguyen P.A., Dasovich N., Sweeney T.D., Hsu C.C., and Shire S.J. The effect of formulation excipients on protein stability and aerosol performance of spray-dried powders of a recombinant humanized anti-IgE monoclonal antibody. Pharm. Res. 16 (1999) 350-358
3. Breen E.D., Curley J.G., Overcashier D.E., Hsu C.C., and Shire S.J. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm. Res. 18 (2001) 1345-1353
4. Chung J.T., Vlugt-Wensink K.D.F., Hennink W.E., and Zhang Z. Effect of polymerization conditions on the network properties of dex-HEMA microspheres and macro-hydrogels. Int. J. Pharm. 288 (2005) 51-61
5. Cleland J.L., and Jones A.J.S. Stable formulations of recombinant human growth hormone and interferon-γ for microencapsulation in biodegradable microspheres. Pharm. Res. 13 (1996) 1464-1475
6. Costantino H.R., Firouzabadian L., Wu C.C., Carrasquillo K.G., Griebenow K., Zale S.E., and Tracy M.A. Protein spray freeze drying 2. Effect of formulation variables on particle size and stability. J. Pharm. Sci. 91 (2002) 388-395
7. Franssen O., Stenekes R.J.H., and Hennink W.E. Controlled release of a model protein from enzymatically degrading dextran microspheres. J. Control. Release 59 (1999) 219-228
8. Frokjaer S., and Otzen D.E. Protein drug stability: a formulation challenge. Nat. Rev. Drug. Discov. 4 (2005) 298-306
9. Fu K., Klibanov A.M., and Langer R. Protein stability in controlled-release systems. Nat. Biotechnol. 18 (2000) 24-25
10. Gnebenow K., and Klibanov A.M. Lyophilization-induced changes in the second structure of proteins. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10969-10976
11. Griebenow K., and Klibanov A.M. On protein denaturation in aqueous-organic mixtures but not in pure organic solvents. JACS 118 (1996) 11695-11700
12. Heller M.C., Carpenter J.F., and Randolph T.W. Manipulation of lyophilization-induced phase separation: implications for pharmaceutical proteins. Biotechnol. Prog. 13 (1997) 590-596
13. Heller M.C., Carrenter J.F., and Randolph T.W. Conformational stability of lyophilized PEGylated proteins in a phase-separating system. J. Pharm. Sci. 88 (1999) 58-64
14. Hennink W.E., Franssen O., vanDijkWolthuis W.N.E., and Talsma H. Dextran hydrogels for the controlled release of proteins. J. Control. Release 48 (1997) 107-114
15. Jin, T., Zhu, H., Zhu, J., 2003. Hazard-free microencapsulation for structurally delicate agents, an application of stable aqueous emulsion. PCT, WO03/101600A2.
16. Johnson O.L., Cleland J.L., Lee H.J., Charnis M., Duenas E., Jaworowica W., Shepard D., Shahzamani A., Jones A.J.S., and Putney S.D. A month-long effect form a single injection of microencapsulated human growth hormone. Nat. Med. 2 (1996) 795-799
17. Kibbe A.H. Handbook of Pharmaceutical Excipients (2000), American Pharmaceutical Association and Pharmaceutical Press, Washing DC and London pp. 336-339
18. Langer R. Moisture-induced aggregation of lyophilization proteins in the solid state. Biotechnol. Bioenerg. 37 (1991) 177-184
19. Morita T., Horikiri Y., Yamahara H., Suzuki T., and Yoshino H. Formation and isolation of spherical fine protein microparticles through lyophilization of protein-poly(ethylene glycol) aqueous mixture. Pharm. Res. 17 (2000) 1367-1373
20. Morlock M., Koll H., Winter G., and Kissel T. Microencapsulation of rh-erythropoietin, using biodegradable poly(d,l-lactide-co-glycolide): protein stability and the effects of stabilizing excipients. Eur. J. Pharm. Biopharm. 43 (1997) 29-36
21. Sah H. Protein behavior at the water/methylene chloride interface. J. Pharm. Sci. 88 (1999) 1320-1325
22. Sanchez A., Villamayor B., Guo Y., Mclver J., and Alonso M.J. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres. Int. J. Pharm. 185 (1999) 255-266
23. Shen T., Wang J.Y., et al. Biochemistry. second ed. (1991), Higher Education Press in China, Beijing p. 183
24. Stenekes R.J.H., De Smedt S.C., Demeester J., Sun G.Z., Zhang Z.B., and Hennink W.E. Pore sizes in hydrated dextran microspheres. Biomacromolecules 1 (2000) 696-703
25. Stenekes R.J.H., Franssen O., van Bommel E.M.G., Crommelin D.J.A., and Hennink W.E. The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm. Res. 15 (1998) 557-561
26. Stenekes R.J.H., Franssen O., van Bommel E.M.G., Crommelin D.J.A., and Hennink W.E. The use of aqueous PEG:dextran phase separation for the preparation of dextran microspheres. Int. J. Pharm. 183 (1999) 29-32
27. Van Tomme S.R., van Steenbergen M.J., De Smedt S.C., van Nostrum C.F., and Hennink W.E. Self-gelling hydrogels based on oppositely charged dextran microspheres. Biomaterials 26 (2005) 2129-2135
28. Wang N., Wu X.S., and Li J.K. A heterogeneously structured composite based on poly(lactic-co-glycolic acid) microspheres and poly(vinyl alcohol) hydrogel nanoparticles for long-term protein drug delivery. Pharm. Res. 16 (1999) 1430-1435
29. Yoshioka S., Aso Y., and Kojima S. Dependence of molecular mobility and protein stability of freeze-dried γ-globulin formulation on the molecula weight of dextran. Pharm. Res. 14 (1997) 736-741
30. Yu Z., Rogers T.L., Hu J., Johnston K.P., and Williams III R.O. Preparation and characterization of microparticles containing peptide produced by a novel process: spray freezing into liquid. Eur. J. Pharm. Biopharm. 54 (2002) 221-228
31. Zale, S.E., Burke, P.A., Berstein, H., Brickner, A., 1998. Composition for sustained release of non-aggregated erythropoietin. US Patent 5,716,644.
32. Zaslavsky B.Y. Aqueous Two-Phase Partitioning: Physical Chemistry and Biological Applications (1995), Marcel Dekker, New York pp. 153-285